Health | Science | Technology | Space | Sports | Entertainment | Mobile | Games | Economy | Politics | Movies | Music | [Top News]

Posts tagged: extends

Disrupting mTORC1 protein complex extends lifespan

March 30, 2012
One of the secrets to a longer, healthier life is simply to eat less. When subjected to calorie restriction (CR), typically defined as a 20-40% reduction in caloric intake with corresponding maintenance of proper nutrition, animals in labs not only live longer, but also have improved insulin sensitivity and glucose ...

Vemurafenib Extends Survival To 16 Months For Some Patients With Metastatic Melanoma

March 20, 2012
An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center in Tampa, Fla., have found that the oral BRAF inhibitor vemurafenib (PLX4032) when tested in a phase II clinical trial offered a high rate of response in patients with previously treated metastatic melanoma ...

DEA Extends Emergency Regulation On Spice And K2 Ingredients

March 2, 2012
The five main chemicals (JWH-018, JWH-073, JWH-200, CP-47,497 and cannabicyclohexanol) that are used to make synthetic marijuana products, have been put under extended emergency scheduling authority, to prohibit possession or selling of both the chemicals and the products that contain them. The additional authority will last for another six months ...

Study extends the ‘ecology of fear’ to fear of parasites

February 27, 2012
(PhysOrg.com) -- Here’s a riddle: What’s the difference between a tick and a lion? The answer used to be that a tick is a parasite and the lion is a predator. But now those definitions don’t seem as secure as they once did.

Roche extends cash tender offer to acquire all shares of Illumina

February 27, 2012
Roche announced today that it has extended its cash tender offer to acquire all outstanding shares of Illumina, Inc., at a price of $44.50 per share, to 6:00 p.m., New York City time, on March 23, 2012.

Oncolytic virus extends survival in medulloblastoma model

February 15, 2012
A strain of measles virus engineered to kill cancer cells prolongs survival in a model of medulloblastoma that is disseminated in the fluid around the brain, according to a new study by researchers at Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove ...

Oncolytic virus extends survival in medulloblastoma model

February 15, 2012
Medulloblastoma is the most common malignant brain tumor in children. Disseminated medulloblastoma is particularly lethal and requires extensive radiation therapy to the brain, which can cause brain damage. An oncolytic measles virus has shown effectiveness in a new model of disseminated human medulloblastoma. ...

Oncolytic virus extends survival in medulloblastoma model

February 15, 2012
(Ohio State University Medical Center) A new study shows that a strain of measles virus engineered to kill cancer cells can prolong survival in a model of medulloblastoma that is disseminated in the fluid around the brain. Treatment with the oncolytic virus called MV-GFP extended survival of animals with disseminated ...

In Patients With Drug-Resistant Prostate Cancer, New Drug Extends Survival

February 2, 2012
A new drug, MDV3100, is improving the survival rate in men with advanced prostate cancer, results of a large, phase III clinical trial show. The drug is designed to block a type of cellular receptor that drives progression of prostate cancer. Based on the strength of the data from the ...

New drug extends survival in patients with drug-resistant prostate cancer

February 1, 2012
A new drug, MDV3100, is improving the survival rate in men with advanced prostate cancer, results of a large, phase III clinical trial show. The drug is designed to block a type of cellular receptor that drives progression of prostate cancer. Based on the strength of the data from the ...

Forensic research extends detection of cyanide poisoning

February 1, 2012
(Sam Houston State University) Researchers have found a new biomarker for cyanide poisoning, which may extend its detection window in death investigations by weeks if not months.

ARCA biopharma extends pharmacogenetic intellectual property protection around bucindolol

December 31, 2011
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for cardiovascular diseases, today announced that the U.S. Patent and Trademark Office has issued a patent on methods for treating patients with bucindolol based on genetic targeting and focused on a specific genotype - homozygous wildtype for Deletion 322-325 in ...